Yong Qing Luo
Chief Executive Officer bei EVEREST MEDICINES LIMITED
Vermögen: 3 Mio $ am 31.03.2024
Aktive Positionen von Yong Qing Luo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EVEREST MEDICINES LIMITED | Director/Board Member | 19.09.2022 | - |
Chief Executive Officer | 19.09.2022 | - | |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | President | 17.09.2020 | - |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Director/Board Member | - | - |
President | - | - |
Karriereverlauf von Yong Qing Luo
Ehemalige bekannte Positionen von Yong Qing Luo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BRII BIOSCIENCES LIMITED | Director/Board Member | 30.03.2021 | 15.09.2022 |
President | 11.09.2020 | 15.09.2022 | |
Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | Corporate Officer/Principal | 01.09.2016 | 01.09.2020 |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Corporate Officer/Principal | 01.08.2012 | 01.08.2016 |
Beijing Novartis Pharma Ltd.
Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Corporate Officer/Principal | 01.06.2009 | 01.08.2012 |
NOVARTIS AG | Corporate Officer/Principal | 01.09.2007 | 01.06.2009 |
Ausbildung von Yong Qing Luo
China Europe International Business School | Masters Business Admin |
Xiangya School of Medicine | Doctorate Degree |
Statistik
International
China | 8 |
Schweiz | 2 |
Cayman Islands | 2 |
Operativ
Corporate Officer/Principal | 4 |
President | 3 |
Director/Board Member | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
NOVARTIS AG | Health Technology |
EVEREST MEDICINES LIMITED | Health Technology |
BRII BIOSCIENCES LIMITED | Commercial Services |
Private Unternehmen | 5 |
---|---|
Beijing Novartis Pharma Ltd.
Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Health Technology |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Health Technology |
Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Yong Qing Luo
- Erfahrung